Extrahepatic manifestations of chronic hepatitis C

Arthritis and Rheumatism

Volumn 42, Issue 10, 1999, Pages 2204-2212

  Cacoub, Patrice ^a   Poynard, Thierry ^a   Ghillani, Pascale ^a   Charlotte, Frederic ^a   Olivi, Martine ^b   Piette, Jean Charles ^a   Opolon, Pierre ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Pharmacy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CRYOGLOBULIN; HEPATITIS B SURFACE ANTIGEN; THYROXINE;

ARTHRALGIA; ARTICLE; CLINICAL FEATURE; HEPATITIS C; HUMAN; LIVER FIBROSIS; MYALGIA; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; SJOEGREN SYNDROME; THYROXINE BLOOD LEVEL;

ADULT; AUTOIMMUNE DISEASES; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 0033502709     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D     Document Type: Article

References (79)

1. Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Intern Med 1996;125:658-68.
2. Gumber SC, Chopra SC. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995;123: 615-20.
3. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994;19:841-8.
4. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-9.
5. Richardet JP, Lons T, Johanet C, Abourached A, Raffoux C, Grimbert S, et al. Prévalence et caractéristiques des anticorps anti-tissus au cours des hépatites chroniques dues au virus de l'hépatite C. Gastroenterol Clin Biol 1994;18:819-23.
6. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C: the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997;349: 825-32.
7. Musset L, Diemert MC, Taibi F, Thi Huong Du L, Cacoub P, Léger JM, et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992;38:798-802.
8. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974;57:775-88.
9. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.
10. Ábel G, Zhang Q-X, Agnello V. Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 1993;36:1341-9.
11. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.
12. Bédossa P, Poynard T, and the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-93.
13. Seigel LB, Cohn L, Nashel D. Rheumatic manifestations of hepatitis C infection. Semin Arthritis Rheum 1993;23:149-54.
14. Perrot S, Job-Deslandre C, Puéchal X, Menkes C-J. Hepatitis C virus related polyarthritis: 11 cases [abstract]. Arthritis Rheum 1994;37 Suppl 9:S234.
15. Ueno Y, Kinoshita R, Kishimoto I, Okamoto S. Polyarthritis associated with hepatitis C virus infection. Br J Rheumatol 1994; 33:289-91.
16. Ripault MP, Borderie C, Dumas P, Vallat JM, Goujon JM, Brecheteau P, et al. Neuropathies périphériques et hépatite virale C: une association fréquente? Gastroenterol Clin Biol 1998;22: 891-6.
17. Apartis E, Léger JM, Musset L, Gugenheim M, Cacoub P, Lyon Caen O, et al. Peripheral neuropathy associated with essential mixed cryoglobulinemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry 1996;60:661-6.
18. Ferri C, La Civita L, Cirafisi C, Siciliano G, Longombardo G, Bombardieri S, et al. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J Rheumatol 1992;19:889-95.
19. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, André C, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995;122:169-73.
20. Dupin N, Chosidow O, Lunel F, Cacoub P, Musset L, Cresta P, et al. Essential mixed cryoglobulinemia: a comparative study of dermatologie manifestations in patients infected or non infected with hepatitis C virus. Arch Dermatol 1995;131:1124-7.
21. Donada C, Crucitti A, Donadon V, Tommasi L, Zanette G, Crovatto M, el al. Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinemia. J Viral Hepat 1998;5:179-85.
22. D'Alessandro Gandolfo L, Biolcati G, Griso D, Macri A, Topi G. Frequency of viral hepatitis markers in porphyria cutanea tarda. Eur J Dermatol 1993;3:180-2.
23. Cribier B, Petiau P, Keller F, Schmitt C, Vetter D, Heid E, et al. Porphyria cutanea tarda and hepatitis C virus infection: a clinical and virological study. Arch Dermatol 1995;131:801-4.
24. Fargion S, Piperno A, Cappelini MD, Sampietro M, Francanzini AL, Romano R, et al. Hepatitis C virus and porphyria cutanea tarda: evidence for a strong association. Hepatology 1992;16: 1322-6.
25. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993;341:788-9.
26. De Castro M, Sanchez J, Herrera JF, Chaves A, Duran R, Garcia-Buey L, et al. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993;17: 551-7.
27. Murphy A, Dooley S, Hillary IB, Murphy GM. Hepatitis C virus infection in porphyria cutanea tarda. Lancet 1993;341:1534-5.
28. Strötzel U, Köstler E, Koszka C, Stöffler-Meilicke M, Schuppan D, Somasundaram R, et al. Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany. Hepatology 1995;21:1500-2.
29. Salmon P, Oakley A, Rademaker M, Duffill M. Hepatitis C virus infection and porphyria cutanea tarda in Australia [letter]. Arch Dermatol 1996;132:91.
30. Lacour JP, Bodokh I, Castanet J, Bekri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993;128:121-3.
31. Cribier B, Garnier C, Laustriat D, Heid E. Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 1994;31:1070-2.
32. Jubert C, Pawlotsky JM, Pouget F, André C, Deforges L, Bretagne S, et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994;130:73-6.
33. Mokni M, Rybojad M, Puppin D, Catala S, Venazia F, Djian R, et al. Lichen planus and hepatitis C virus [letter]. J Am Acad Dermatol 1991;24:792.
34. Sanchez-Perez J, De Castro M, Buezo GF, Fernandez-Herera J, Borque MJ, Garcia-Diez A. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol 1996;134:715-9.
35. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-3.
36. Mariette X, Zerbib M, Jaccard A, Schenmetzeler C, Danon F, Clauvel J-P. Hepatitis C virus and Sjögren's syndrome. Arthritis Rheum 1993;36:280-1.
37. Almasio P, Provenzano G, Scimemi M, Cascio G, Craxi A, Pagliaro L. Hepatitis C virus and Sjögren's syndrome. Lancet 1992;339:989-90.
38. Jorgensen C, Legouffe M-C, Perney P, Coste J, Tissot B, Segarra C, et al. Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996;39:1166-71.
39. Aceti A, Taliani G, Sorice M, Amendolea MA. Hepatitis C virus and Sjögren's syndrome. Lancet 1992;339:1425-6.
40. King PD, McMurray RW, Becherer PR. Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 1994;89:1047-50.
41. Boscagli A, Hatron PY, Canva-Delcambre V, Hachulla E, Janin A, Paris C, et al. Syndrome sec et infection par Ie virus de l'hépatite C: un pseudosyndrome de Gougerot-Sjögren. Rev Med Interne 1996;17:375-80.
42. Wattiaux MJ, Jouan-Flahault C, Youinou P, Cabane J, Andreani T, Serfaty L, et al. Association of Gougerot-Sjögren syndrome and viral hepatitis C. Ann Med Interne 1995;146:247-50.
43. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 1991;34:1606-10.
44. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117:573-7.
45. Cacoub P, Musset L, Lunel-Fabiani F, Léger JM, Le Thi Huong D, Wechsler B, et al. Hepatitis C virus and essential mixed cryoglobulinemia. Br J Rheumatol 1993;32:685-92.
46. Marcellin P, Deschamps V, Martinot-Peignoux M, Larzul D, Xu L, Boyer N, et al. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 1993;104:272-7.
47. Cacoub P, Lunel-Fabiani F, Musset L, Perrin M, Frangeul L, Leger JM, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-32.
48. Cacoub P, Lunel-Fabiani F, Le Thi Huong D. Polyarteritis nodosa and hepatitis C infection. Ann Intern Med 1992;116:605-6.
49. Dény P, Bonacorsi S, Guillevin L, Quint L. Association between hepatitis C virus and polyarteritis nodosa. Clin Exp Rheumatol 1992;10:319-24.
50. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993;20:304-9.
51. Borque L, Elena A, Maside C, Rus A, Del Cura J. Rheumatoid arthritis and hepatitis C virus antibodies. Clin Exp Rheumatol 1991;9:617-9.
52. Lovy MR, Sarkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996;23:979-83.
53. Ferri C, La Civita L, Fazzi P, Pasero G, Zignego AL. Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection [letter]. Arthritis Rheum 1996;39:1074-5.
54. Agnello V, Chung RT, Kaphan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327: 1490-5.
55. Wong VS, Egner W, Elsey T, Brown D, Alexander GJ. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996;104:25-31.
56. Cacoub P, Frangeul L, Lunel F, Musset L, Piette J-C, Opolon P, et al. Mixed cryoglobulinemia and hepatitis C virus infection: a multivariate analysis [abstract]. Arthritis Rheum 1995;38 Suppl 9:S199.
57. Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996;124:31-4.
58. Frangeul L, Musset L, Cresta P, Cacoub P, Huraux JM, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia. J Hepatol 1996;25:427-32.
59. Willems M, Sheng L, Roskams T, Ramdani B, Doutrelepont JM, Nevens F, et al. Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome. J Med Virol 1994;44:266-71.
60. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994;106:1291-300.
61. Fayyazi A, Schott P, Hartmann H, Mihm S, Middel P, Ramadori G, et al. Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia. Gastroenterology 1997;35:921-8.
62. Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo A, Monteverde M, et al. Cryoglobulinemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. QJM 1995;88:115-26.
63. Ferri C, Zignego AL, Bombardieri S, La Civita L, Longobardo G, Motini M, et al. Etiopathogenic role of hepatitis C virus in mixed cryoglobulinemia, liver diseases and lymphoma. Clin Exp Rheumatol 1995;13:135-40.
64. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-4.
65. Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996;94:544-50.
66. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gutekunst K, Mizokami M, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997;127:423-8.
67. McColl MD, Singer IO, Tait RC, McNeil IRR, Cumming RLC, Hogg RB. The role of hepatitis C virus in the aetiology of non-Hodgkin's lymphoma - a regional association? Leuk Lymphoma 1997;26:127-30.
68. Hausfater P, Cacoub P, Bernard N, Loustaud-Ratti V, Le Lostec Z, Laurichesse H, et al. Hepatitis C virus infection and malignant lymphoproliferative disease: French national study [abstract]. Arthritis Rheum 1998;41 Suppl 9:S307.
69. Germanidis G, Haioun C, Pourquier J, Gaulard P, Pawlotsky JM, Dumeaux D, et al. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center [letter]. Blood 1999;33:1778-9.
70. Ferri C, La Civita L, Monti M, Longombardo G, Greco F, Pasero G, et al. Can type C hepatitis infection be complicated by malignant lymphoma? [letter]. Lancet 1995;346:1426-7.
71. Abuaf N, Lunel F, Giral P, Borotto E, Laperche S, Poupon R, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993;18:359-64.
72. Cacoub P, Renou C, Cohen P, Yamamoto AM, Musset L, Camperoux A, et al. Extrahepatic manifestations of hepatitis C virus infection: a French prospective multicenter study with multivariate analysis in 298 patients [abstract]. Arthritis Rheum 1997;40 Suppl 9:S92.
73. Borotto E, Lunel F, Valla D, Abuaf N, Perrin M, Bousquet JC, et al. Prevalence et signification des anticorps anti-organites non spécifiques du foie au cours des hépatites chroniques virales C. Gastroenterol Clin Biol 1994;18:813-8.
74. Cacoub P, Musset L, Hausfater P, Ghillani P, Fabiani F, Charlotte F, et al. No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus infection (HCV) with or without cryoglobulinemia. Clin Exp Immunol 1998;113:48-54.
75. Cacoub P, Musset L, Amoura Z, Ghillani P, Chabre H, Lunel F, et al. Anti-cardiolipin, anti-β2 glycoprotein 1, and antinucleosome antibodies in hepatitis C virus infection with or without mixed cryoglobulinemia. J Rheumatol 1997;24:2139-44.
76. Tran A, Quaranta JF, Benzaken S. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993;18: 253-7.
77. Marcellin P, Pouteau M, Benhamou JP. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol 1995;22:364-9.
78. Doullay F, Ruf J, Codaccioni JL, Carrayon P. Prevalence of autoantibodies to thyroperoxidase in patients with various thyroid and autoimmune disease. Autoimmunity 1991;9:237-44.
79. Friedman SL. Cellular networks in hepatic fibrosis. Digestion 1998;59:368-71.